October 20, 2025 · Form 4 insider transaction
Altmeyer Anne sold 1,060 shares of CORBUS PHARMACEUTICALS HLDGS at $20.50 per share, a transaction worth $21.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2024.; This amount includes 4,800 unvested RSUs that were granted on May 30, 2025 and vest 100% on the one-year anniversary of the date of grant.